Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H22BrNO3 |
| Molecular Weight | 392.287 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(Br)=C(OC)C2=C1[C@H](CNCC3=CC=CC=C3OC)C2
InChI
InChIKey=CLSBQRBXTFTLEX-ZDUSSCGKSA-N
InChI=1S/C19H22BrNO3/c1-22-16-7-5-4-6-12(16)10-21-11-13-8-14-18(13)17(23-2)9-15(20)19(14)24-3/h4-7,9,13,21H,8,10-11H2,1-3H3/t13-/m0/s1
| Molecular Formula | C19H22BrNO3 |
| Molecular Weight | 392.287 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:15:39 GMT 2023
by
admin
on
Sat Dec 16 10:15:39 GMT 2023
|
| Record UNII |
WGI3S41A26
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-2CBCB-NBOMe
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1354634-09-5
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
PRIMARY | |||
|
WGI3S41A26
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
PRIMARY | |||
|
2CBCB-NBOME
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
PRIMARY | 2CBCB-NBOMe (NBOMe-TCB-2) is a compound indirectly derived from the phenethylamine series of hallucinogens, which was discovered in 2007 at Purdue University as part of the ongoing research program of the team led by David Nichols focusing on the mapping of the specific amino acid residues responsible for ligand binding to the 5HT2A receptor. 2CBCB-NBOMe acts as a potent and selective agonist for the 5-HT2A and 5-HT2C receptors, with a Ki of 0.27nM at the human 5-HT2A receptor, a similar potency to other agonists such as TCB-2, NBOMe-2C-I and Bromo-DragonFLY. | ||
|
DTXSID501028189
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
PRIMARY | |||
|
57483909
Created by
admin on Sat Dec 16 10:15:39 GMT 2023 , Edited by admin on Sat Dec 16 10:15:39 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
